A citation-based method for searching scientific literature

Shinichiro Ohshimo, Nobuhisa Ishikawa, Yasushi Horimasu, Noboru Hattori, Nobuyuki Hirohashi, Koichi Tanigawa, Nobuoki Kohno, Francesco Bonella, Josune Guzman, Ulrich Costabel. Respir Med 2014
Times Cited: 107







List of co-cited articles
830 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
60

Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.
Harold R Collard, Christopher J Ryerson, Tamera J Corte, Gisli Jenkins, Yasuhiro Kondoh, David J Lederer, Joyce S Lee, Toby M Maher, Athol U Wells, Katerina M Antoniou,[...]. Am J Respir Crit Care Med 2016
588
45

Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome.
J W Song, S-B Hong, C-M Lim, Y Koh, D S Kim. Eur Respir J 2011
444
34

Acute exacerbations of idiopathic pulmonary fibrosis.
Harold R Collard, Bethany B Moore, Kevin R Flaherty, Kevin K Brown, Robert J Kaner, Talmadge E King, Joseph A Lasky, James E Loyd, Imre Noth, Mitchell A Olman,[...]. Am J Respir Crit Care Med 2007
748
33

Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis.
Akihito Yokoyama, Keiichi Kondo, Masamitsu Nakajima, Toshiharu Matsushima, Toru Takahashi, Masaharu Nishimura, Masashi Bando, Yukihiko Sugiyama, Yoshitaka Totani, Takeshi Ishizaki,[...]. Respirology 2006
185
30

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
30

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
23

Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases.
Nobuhisa Ishikawa, Noboru Hattori, Akihito Yokoyama, Nobuoki Kohno. Respir Investig 2012
196
22

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
22

Risk factors of acute exacerbation of idiopathic pulmonary fibrosis.
Y Kondoh, H Taniguchi, T Katsuta, K Kataoka, T Kimura, O Nishiyama, K Sakamoto, T Johkoh, M Nishimura, K Ono,[...]. Sarcoidosis Vasc Diffuse Lung Dis 2010
119
22

Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials.
Harold R Collard, Eric Yow, Luca Richeldi, Kevin J Anstrom, Craig Glazer. Respir Res 2013
125
20


An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
19

Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.
Kosuke Hamai, Hiroshi Iwamoto, Nobuhisa Ishikawa, Yasushi Horimasu, Takeshi Masuda, Shintaro Miyamoto, Taku Nakashima, Shinichiro Ohshimo, Kazunori Fujitaka, Hironobu Hamada,[...]. Dis Markers 2016
57
33

Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis.
Antje Prasse, Corinna Probst, Elena Bargagli, Gernot Zissel, Galen B Toews, Kevin R Flaherty, Manfred Olschewski, Paola Rottoli, Joachim Müller-Quernheim. Am J Respir Crit Care Med 2009
216
18

Staging of acute exacerbation in patients with idiopathic pulmonary fibrosis.
Tomoo Kishaba, Hitoshi Tamaki, Yousuke Shimaoka, Hajime Fukuyama, Shin Yamashiro. Lung 2014
86
20

New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6.
N Kohno, S Kyoizumi, Y Awaya, H Fukuhara, M Yamakido, M Akiyama. Chest 1989
358
17

MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis.
Ivan O Rosas, Thomas J Richards, Kazuhisa Konishi, Yingze Zhang, Kevin Gibson, Anna E Lokshin, Kathleen O Lindell, Jose Cisneros, Sandra D Macdonald, Annie Pardo,[...]. PLoS Med 2008
357
17

Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.
Hiroshi Ohnishi, Akihito Yokoyama, Keiichi Kondo, Hironobu Hamada, Masahiro Abe, Kazutaka Nishimura, Kunio Hiwada, Nobuoki Kohno. Am J Respir Crit Care Med 2002
269
17

Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences.
Motoki Natsuizaka, Hirofumi Chiba, Koji Kuronuma, Mitsuo Otsuka, Kazumi Kudo, Mitsuru Mori, Masashi Bando, Yukihiko Sugiyama, Hiroki Takahashi. Am J Respir Crit Care Med 2014
237
17

Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
Brett Ley, Harold R Collard, Talmadge E King. Am J Respir Crit Care Med 2011
914
17

Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features.
D S Kim, J H Park, B K Park, J S Lee, A G Nicholson, T Colby. Eur Respir J 2006
313
16

Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure.
Kerri A Johannson, Eric Vittinghoff, Kiyoung Lee, John R Balmes, Wonjun Ji, Gilaad G Kaplan, Dong Soon Kim, Harold R Collard. Eur Respir J 2014
131
16

Prognostic value of serial serum KL-6 measurements in patients with idiopathic pulmonary fibrosis.
Kentaro Wakamatsu, Nobuhiko Nagata, Hiroyuki Kumazoe, Keishi Oda, Hiroshi Ishimoto, Michihiro Yoshimi, Shohei Takata, Minako Hamada, Yoshifusa Koreeda, Kouji Takakura,[...]. Respir Investig 2017
49
32

KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease.
N Kohno, Y Awaya, T Oyama, M Yamakido, M Akiyama, Y Inoue, A Yokoyama, H Hamada, S Fujioka, K Hiwada. Am Rev Respir Dis 1993
209
15

Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis.
Jin Woo Song, Kyung Hyun Do, Se Jin Jang, Thomas V Colby, Seungbong Han, Dong Soon Kim. Chest 2013
83
18

Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis.
A Yokoyama, N Kohno, H Hamada, M Sakatani, E Ueda, K Kondo, Y Hirasawa, K Hiwada. Am J Respir Crit Care Med 1998
163
15

Risk factors for acute exacerbation of idiopathic pulmonary fibrosis--Extended analysis of pirfenidone trial in Japan.
Yasuhiro Kondoh, Hiroyuki Taniguchi, Masahito Ebina, Arata Azuma, Takashi Ogura, Yoshio Taguchi, Moritaka Suga, Hiroki Takahashi, Koichiro Nakata, Yukihiko Sugiyama,[...]. Respir Investig 2015
37
37

Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses.
Rehan A Kahloon, Jianmin Xue, Arpit Bhargava, Eva Csizmadia, Leo Otterbein, Daniel J Kass, Jessica Bon, Makoto Soejima, Marc C Levesque, Kathleen O Lindell,[...]. Am J Respir Crit Care Med 2013
119
14

Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study.
Marco Mura, Maria A Porretta, Elena Bargagli, Gianluigi Sergiacomi, Maurizio Zompatori, Nicola Sverzellati, Amedeo Taglieri, Fabrizio Mezzasalma, Paola Rottoli, Cesare Saltini,[...]. Eur Respir J 2012
131
14

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
14

Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis.
Harold R Collard, Carolyn S Calfee, Paul J Wolters, Jin Woo Song, Sang-Bum Hong, Sandra Brady, Akitoshi Ishizaka, Kirk D Jones, Talmadge E King, Michael A Matthay,[...]. Am J Physiol Lung Cell Mol Physiol 2010
128
14

Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis.
I-Nae Park, Dong Soon Kim, Tae Sun Shim, Chae-Man Lim, Sang Do Lee, Younsuck Koh, Woo Sung Kim, Won Dong Kim, Se Jin Jang, Thomas V Colby. Chest 2007
218
14

Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis.
Antje Moeller, Sarah E Gilpin, Kjetil Ask, Gerard Cox, Deborah Cook, Jack Gauldie, Peter J Margetts, Laszlo Farkas, Julian Dobranowski, Colm Boylan,[...]. Am J Respir Crit Care Med 2009
359
13

Pirfenidone in idiopathic pulmonary fibrosis.
H Taniguchi, M Ebina, Y Kondoh, T Ogura, A Azuma, M Suga, Y Taguchi, H Takahashi, K Nakata, A Sato,[...]. Eur Respir J 2010
623
13

Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm.
Christopher J Ryerson, Vincent Cottin, Kevin K Brown, Harold R Collard. Eur Respir J 2015
97
13

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
Luca Richeldi, Ulrich Costabel, Moises Selman, Dong Soon Kim, David M Hansell, Andrew G Nicholson, Kevin K Brown, Kevin R Flaherty, Paul W Noble, Ganesh Raghu,[...]. N Engl J Med 2011
663
13

Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis.
Brent W Kinder, Kevin K Brown, Francis X McCormack, Joachim H Ix, Alma Kervitsky, Marvin I Schwarz, Talmadge E King. Chest 2009
140
13

KL-6: a serum marker for interstitial pneumonia.
J Kobayashi, S Kitamura. Chest 1995
164
13

Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.
Joyce S Lee, Harold R Collard, Kevin J Anstrom, Fernando J Martinez, Imre Noth, Rhonda S Roberts, Eric Yow, Ganesh Raghu. Lancet Respir Med 2013
247
12

Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis.
Masanori Akira, Takenori Kozuka, Satoru Yamamoto, Mitsunori Sakatani. Am J Respir Crit Care Med 2008
130
12

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
923
12

Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic.
Ryo Tachikawa, Keisuke Tomii, Hiroyuki Ueda, Kazuma Nagata, Shigeki Nanjo, Ayako Sakurai, Kyoko Otsuka, Reiko Kaji, Michio Hayashi, Nobuyuki Katakami,[...]. Respiration 2012
83
14

C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis.
Louis J Vuga, John R Tedrow, Kusum V Pandit, Jiangning Tan, Daniel J Kass, Jianmin Xue, Divay Chandra, Joseph K Leader, Kevin F Gibson, Naftali Kaminski,[...]. Am J Respir Crit Care Med 2014
101
12

Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis.
Philip L Molyneaux, Michael J Cox, Athol U Wells, Ho Cheol Kim, Wonjun Ji, William O C Cookson, Miriam F Moffatt, Dong Soon Kim, Toby M Maher. Respir Res 2017
99
12

Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.
Anna L Peljto, Yingze Zhang, Tasha E Fingerlin, Shwu-Fan Ma, Joe G N Garcia, Thomas J Richards, Lori J Silveira, Kathleen O Lindell, Mark P Steele, James E Loyd,[...]. JAMA 2013
273
11

Molecular biomarkers in idiopathic pulmonary fibrosis.
Brett Ley, Kevin K Brown, Harold R Collard. Am J Physiol Lung Cell Mol Physiol 2014
107
11

Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis.
Nicoline M Korthagen, Coline H M van Moorsel, Nicole P Barlo, Henk J T Ruven, Adrian Kruit, Michiel Heron, Jules M M van den Bosch, Jan C Grutters. Respir Med 2011
81
13

Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.
Thomas J Richards, Naftali Kaminski, Fred Baribaud, Susan Flavin, Carrie Brodmerkel, Daniel Horowitz, Katherine Li, Jiin Choi, Louis J Vuga, Kathleen O Lindell,[...]. Am J Respir Crit Care Med 2012
248
11

Viral infection in acute exacerbation of idiopathic pulmonary fibrosis.
Sharon Chao Wootton, Dong Soon Kim, Yasuhiro Kondoh, Eunice Chen, Joyce S Lee, Jin Woo Song, Jin Won Huh, Hiroyuki Taniguchi, Charles Chiu, Homer Boushey,[...]. Am J Respir Crit Care Med 2011
156
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.